Topics
- Cancer stem cells and mechanisms of malignant progression
- Building an antibody discovery company in a crowded field
- Risk factors that contribute to immunogenicity
- Risk assessment and predictive strategies
- Controlling immunogenicity/immunosuppressive mechanisms
- Tools for immunogenicity risk prediction
- New approaches to tolerance induction
- Immune suppression and deimmunization
Who should Attend
Senior executives and scientists from Pharmaceutical companies, laboratories, Bio-research Centers, universities, government and more.
